Theaflavins target Fas/caspase-8 and Akt/pBad pathways to induce apoptosis in p53-mutated human breast cancer cells

Carcinogenesis

Volumn 31, Issue 2, 2010, Pages 259-268

  Lahiry, Lakshmishri ^a   Saha, Baisakhi ^a   Chakraborty, Juni ^a   Adhikary, Arghya ^a   Mohanty, Suchismita ^a   Hossain, Dewan Md Sakib ^a   Banerjee, Shuvomoy ^a   Das, Kaushik ^a   Sa, Gaurisankar ^a   Das, Tanya ^a  

^a BOSE INSTITUTE   (India)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; CASPASE 8; CASPASE 9; CYTOCHROME C; FAS ANTIGEN; FAS ASSOCIATED DEATH DOMAIN PROTEIN; FAS LIGAND; PROTEIN BAD; PROTEIN BCL 2; PROTEIN BCL XL; PROTEIN BID; PROTEIN KINASE B; PROTEIN P53; STRESS ACTIVATED PROTEIN KINASE; THEAFLAVIN; ANTIOXIDANT; BAD PROTEIN, HUMAN; BIFLAVONOID; CATECHIN; FAS PROTEIN, HUMAN; MESSENGER RNA; SMALL INTERFERING RNA; TP53 PROTEIN, HUMAN;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CELL SURVIVAL; CONTROLLED STUDY; DRUG TARGETING; ENZYME ACTIVATION; ENZYME INACTIVATION; ENZYME RELEASE; GENE MUTATION; HUMAN; HUMAN CELL; MITOCHONDRIAL MEMBRANE POTENTIAL; MITOCHONDRIAL PERMEABILITY; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DEPHOSPHORYLATION; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; UPREGULATION; BREAST TUMOR; DRUG ANTAGONISM; DRUG EFFECT; ENZYME IMMUNOASSAY; FEMALE; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; GENETIC TRANSFECTION; GENETICS; IMMUNOPRECIPITATION; METABOLISM; MITOCHONDRION; MUTATION; PATHOLOGY; PHOSPHORYLATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR CELL CULTURE; WESTERN BLOTTING;

ANTIGENS, CD95; ANTIOXIDANTS; APOPTOSIS; BCL-ASSOCIATED DEATH PROTEIN; BIFLAVONOIDS; BLOTTING, WESTERN; BREAST NEOPLASMS; CASPASE 8; CASPASE 9; CATECHIN; CYTOCHROMES C; FAS-ASSOCIATED DEATH DOMAIN PROTEIN; FEMALE; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; IMMUNOENZYME TECHNIQUES; IMMUNOPRECIPITATION; MEMBRANE POTENTIAL, MITOCHONDRIAL; MITOCHONDRIA; MUTATION; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; TRANSFECTION; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEIN P53;

EID: 77649207635     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgp240     Document Type: Article

References (60)

1. Okonkwo, Q.L. et al. (2008) Breast cancer screening policies in developing countries: a cost-effectiveness analysis for India. J. Natl. Cancer Inst., 100, 1290-1300.
2. Thomadaki, H. et al. (2008) Breast versus ovarian cancer cells' molecular profile as a response to treatment with the anticancer drugs cisplatin, carboplatin, doxorubicin, etoposide and taxol. Biol. Chem., 389, 1427-1434.
3. Qiu, W. et al. (2008) Retinoblastoma protein modulates gankyrin-MDM2 in regulation of p53 stability and chemosensitivity in cancer cells. Oncogene, 27, 4034-4043.
4. Nishiyama, H. et al. (2008) p53 and chemosensitivity in bladder cancer. Int. J. Clin. Oncol., 13, 282-286.
5. Frebourg, T. (1997) Germline mutations of the p53 gene. Pathol. Biol. (Paris), 45, 845-851.
6. Scata, K.A. et al. (2007) p53, BRCA1 and breast Cancer chemoresistance. Adv. Exp. Med. Biol., 608, 70-86.
7. Lahiry, L. et al. (2008) Contribution of p53-mediated Bax transactivation in theaflavin-induced mammary epithelial carcinoma cell apoptosis. Apoptosis, 13, 771-781.
8. Way, T.D. et al. (2004) Black tea polyphenol theaflavins inhibit aromatase activity and attenuate tamoxifen resistance in HER2/neu-transfected human breast cancer cells through tyrosine kinase suppression. Eur. J. Cancer, 40, 2165-2174.
9. Stel, A.J. et al. (2007) Fas receptor clustering and involvement of the death receptor pathway in rituximab-mediated apoptosis with concomitant sensitization of lymphoma B cells to fas-induced apoptosis. J. Immunol., 178, 2287-2295.
10. Nagata, S. (1999) Fas ligand-induced apoptosis. Annu. Rev. Genet., 33, 29-55.
11. Köhler, B. et al. (2008) Bid participates in genotoxic drug-induced apoptosis of HeLa cells and is essential for death receptor ligands' apoptotic and synergistic effects. PLoS ONE, 3, e2844.
12. Li, T. et al. (2006) Inhibition of caspase-8 attenuates neuronal death induced by limbic seizures in a cytochrome c-dependent and Smac/DIABLO-independent way. Brain Res., 1098, 204-211.
13. Cantley, L.C. (2002) The phosphoinositide 3-kinase pathway. Science, 296, 1655-1657.
14. Cheung, S.M. et al. (2007) Regulation of phosphoinositide 3-kinase signaling by oxidants: hydrogen peroxide selectively enhances immunoreceptorinduced recruitment of phosphatidylinositol (3, 4) bisphosphate-binding PH domain proteins. Cell. Signal., 19, 902-912.
15. Opel, D. et al. (2007) Activation of Akt predicts poor outcome in neuroblastoma. Cancer Res., 67, 735-745.
16. Kuo, C.T. et al. (2008) Denbinobin induces apoptosis in human lung adenocarcinoma cells via Akt inactivation, Bad activation, and mitochondrial dysfunction. Toxicol. Lett., 177, 48-58.
17. Bhattacharyya, A. et al. (2003) Apoptogenic effects of black tea on Ehrlich's ascites carcinoma cell. Carcinogenesis, 24, 75-80.
18. Bhattacharyya, A. et al. (2005) Black tea induces tumor cell apoptosis by Bax translocation, loss in mitochondrial transmembrane potential, cytochrome c release and caspase activation. Int. J. Cancer, 117, 308-315.
19. Kalra, N. et al. (2007) Theaflavins induced apoptosis of LNCaP cells is mediated through induction ofp53, down-regulation of NF-kappa B and mitogen-activated protein kinases pathways. Life Sci., 80, 2137-2146.
20. Kundu, T. et al. (2005) Induction of apoptosis in human leukemia cells by black tea and its polyphenols theaflavin. Cancer Lett., 230, 111-121.
21. Earnshaw, W.C. et al. (1999) Mammalian caspases: structure, activation, substrates, and functions during apoptosis. Annu. Rev. Biochem., 68, 383-424.
22. Ashikenazi, A. et al. (1998) Death receptors: signaling and modulation. Science, 281, 1305-1308.
23. Edinger, A.L. et al. (2002) Akt maintains cell size and survival by increasing mTOR-dependent nutrient uptake. Mol. Biol. Cell, 13, 2276-2288.
24. Shi, Y. (2008) Apoptosome assembly. Methods Enzymol., 442, 141-156.
25. Weir, H.K. et al. (2001) The protein kinase PKB/Akt regulates cell survival and apoptosis by inhibiting Bax conformational change. Oncogene, 20, 7779-7786.
26. Whibley, C. et al. (2009) p53 polymorphisms: cancer implications. Nat. Rev. Cancer, 9, 95-107.
27. Manson, M.M. et al. (2000) Blocking and suppressing mechanisms of chemoprevention by dietary constituents. Toxicol. Lett., 113, 499-505.
28. Miyashita, T. et al. (1995) Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell, 80, 293-299.
29. Amin, A.R.M.R. et al. (2007) SHP-2 tyrosine phosphatase inhibits p73-dependent apoptosis and expression of a subset of p53 target genes induced by EGCG. Proc. Natl. Acad. Sci. USA, 104, 5419-5424.
30. Hastak, K. et al. (2003) Role of p53 and NF-kappaB in epigallocatechin-3-gallate-induced apoptosis of LNCaP cells. Oncogene, 22, 4851-4859.
31. Bush, J.A. et al. (2001) Curcumin induces apoptosis in human melanoma cells through a Fas receptor/caspase-8 pathway independent of p53. Exp. Cell Res., 271, 305-314.
32. Shammas, M.A. et al. (2006) Specific killing of multiple myeloma cells by (-)-epigallocatechin-3-gallate extracted from green tea: biologic activity and therapeutic implications. Blood, 108, 2804-2810.
33. Chen, K.C. et al. (2009) JNK1/c-Jun and p38alpha MAPK/ATF-2 pathways are responsible for upregulation of Fas/FasL in human chronic myeloid leukemia K562 cells upon exposure to Taiwan cobra phospholipase A(2). J. Cell. Biochem., 108, 612-620.
34. Bhattacharya, U. et al. (2009) Role of oxidation-triggered activation of JNK and p38 MAPK in black tea polyphenols induced apoptotic death of A375 cells. Cancer Sci., 100, 1971-1978.
35. Micheau, O. et al. (1999) Fas ligand-independent, FADD-mediated activation of the Fas death pathway by anticancer drugs. J. Biol.Chem., 274, 7987-7992.
36. Shao, R.G. et al. (2001) Activation of the Fas pathway independently of Fas ligand during apoptosis induced by camptothecin in p53 mutant human colon carcinoma cells. Oncogene, 20, 1852-1859.
37. Hayakawa, S. et al. (2001) Apoptosis induction by epigallocatechin gallate involves its binding to Fas. Biochem. Biophys. Res. Commun., 285, 1102-1106.
38. Chen, Y.L. et al. (2005) Inhibition of PI3K/Akt signaling: an emerging paradigm for targeted cancer therapy. Curr. Med. Chem. Anticancer Agents, 5, 575-589.
39. Brognard, J. et al. (2001) Akt/protein kinase B is constitutively active in non-small cell lung cancer cells and promotes cellular survival and resistance to chemotherapy and radiation. Cancer Res., 61, 3986-3997.
40. Schuurbiers, O.C. et al. (2009) The PI3-K/AKT-pathway and radiation resistance mechanisms in non-small cell lung cancer. J. Thorac. Oncol., 4, 761-767.
41. Moral, M. et al. (2008) Akt pathway as a target for therapeutic intervention in HNSCC. Histol. Histopathol., 23, 1269-1278.
42. Wang, Y.A. et al. (2009) Differential enhancement of the anti-cancer effect of doxorubicin by Akt inhibitors on human breast cancer cells with differing genetic backgrounds. Oncol. Rep., 21, 437-442.
43. Pommier, Y. et al. (2004) Apoptosis defects and chemo-therapy resistance: molecular interaction maps and networks. Oncogene, 23, 2934-2949.
44. Nakashio, A. et al. (2000) Prevention of phosphatidylinositol 3#-kinase-Akt survival signaling pathway during topotecan-induced apoptosis. Cancer Res., 60, 5303-5309.
45. Kim, S.J. et al. (2009) Urinary trypsin inhibitors afford cardioprotective effects through activation of PI3K-Akt and ERK signal transduction and inhibition of p38 MAPK and JNK. Cardiology, 114, 264-270.
46. Szanto, A. et al. (2009) Critical role of bad phosphorylation by Akt in cytostatis resistance of human bladder cancer cells. Anticancer Res., 29, 159-164.
47. Franke, T.F. et al. (2003) PI3K/Akt and apoptosis: size matters. Oncogene, 22, 8983-8998.
48. Cicenas, J. (2008) The potential role of Akt phosphorylation in human cancers. Int. J. Biol. Markers, 23, 1-9.
49. Zhu, N. et al. (2008) Inhibition of the Akt/survivin pathway synergizes the antileukemia effect of nutlin-3 in acute lymphoblastic leukemia cells. Mol. Cancer Ther., 7, 1101-1109.
50. Chen, J.S. et al. (2008) Characterization of structurally distinct, isoformselective phosphoinositide 3'-kinase inhibitors in combination with radiation in the treatment of glioblastoma. Mol. Cancer Ther., 7, 841-850.
51. Sartelet, H. et al. (2008) AKT pathway in neuroblastoma and its therapeutic implication. Expert Rev. Anticancer Ther., 8, 757-769.
52. Lee, D.H. et al. (2008) Role of Bax in quercetin-induced apoptosis in human prostate cancer cells. Biochem. Pharmacol., 75, 2345-2355.
53. Billen, L.P. et al. (2008) Bcl-XL inhibits membrane permeabilization by competing with Bax. PLoS Biol., 6, e147.
54. Suzuki, E. et al. (2007) Rituximab inhibits the constitutively activated PI3K-Akt pathway in B-NHL cell lines: involvement in chemosensitization to drug-induced apoptosis. Oncogene, 26, 6184-6193.
55. Jeong, S.Y. et al. (2004) Bcl-x(L) sequesters its C-terminal membrane anchor in soluble, cytosolic homodimers. EMBO J., 23, 2146-2155.
56. Lamy, V. et al. (2008) Lupulone, a hop bitter acid, activates different death pathways involving apoptotic TRAIL-receptors, in human colon tumor cells and in their derived metastatic cells. Apoptosis, 13, 1232-1242.
57. Basu, A. et al. (2006) Crosstalk between extrinsic and intrinsic cell death pathways in pancreatic cancer: synergistic action of estrogen metabolite and ligands of death receptor family. Cancer Res., 66, 4309-4318.
58. Wiseman, S. et al. (2001) Tea flavonoids: bioavailability in vivo and effects on cell signaling pathways in vitro. Antioxid. Redox Signal., 3, 1009-1021.
59. Mulder, T.P. et al. (2001) Analysis of theaflavins in biological fluids using liquid chromatography-electrospray mass spectrometry. J. Chromatogr. B Biomed. Sci. Appl., 760, 271-279.
60. Henning, S.M. et al. (2006) Tea polyphenols and theaflavins are present in prostate tissue of humans and mice after green and black tea consumption. J. Nutr., 136, 1839-1843.